Selecta Biosciences appoints Peter Keller vice-president and alliance manager
This article was originally published in Scrip
Executive Summary
Selecta Biosciences, a biopharmaceutical company developing targeted vaccines and immunotherapies, has appointed Peter Keller vice-president of business development and alliance manager. Prior to joining Selecta, Mr Keller led the integration process for Abbott Laboratories' R&D and manufacturing facilities. He will report to Dr Werner Cautreels, Selecta's CEO.